Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd (GUJTHEM) last traded at ₹410, a market capitalisation of ₹4,463 crore, on a P/E of 91.7. Over the past 52 weeks the stock has ranged between ₹225 and ₹479. Gujarat Themis Biosyn Ltd last reported results for the quarter ended Jun 2026, with sales of ₹44 crore and net profit of ₹11 crore. Figures are as of 25 Aug 2026 and are not real time.
Gujarat Themis Biosyn Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Gujarat Themis Biosyn Ltd quarterly results
| ₹ crore | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 36 | 44 | 44 |
| Expenses | 22 | 25 | 23 |
| Operating profit | 14 | 19 | 21 |
| OPM % | 39% | 44% | 48% |
| Other income | 0 | 1 | 0 |
| Interest | 0 | 2 | 2 |
| Depreciation | 2 | 4 | 4 |
| Profit before tax | 12 | 14 | 15 |
| Tax % | 25% | 24% | 27% |
| Net profit | 9 | 11 | 11 |
| EPS (₹) | 0.83 | 1.00 | 1.02 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Gujarat Themis Biosyn Ltd annual results
| ₹ crore | Mar 2026 |
|---|---|
| Sales | 166 |
| Operating profit | 76 |
| OPM % | 46% |
| Net profit | 47 |
| EPS (₹) | 4.28 |
TTM is the trailing twelve months to the most recent quarter.
Gujarat Themis Biosyn Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- 51%
- 5 Years
- 49%
- 3 Years
- 57%
- 1 Year
- 3%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Gujarat Themis Biosyn Ltd shareholding pattern
Promoters held 70.87% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.76% and DIIs 1.17%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 70.87% | 70.87% | 70.87% | 70.87% | 70.87% | 70.87% | 70.86% | 70.87% |
| FIIs | 1.49% | 1.42% | 1.91% | 2.51% | 2.95% | 1.96% | 1.80% | 1.76% |
| DIIs | 1.17% | 1.17% | 1.17% | 1.17% | 1.17% | 1.17% | 1.17% | 1.17% |
| Public | 26.47% | 26.55% | 26.05% | 25.44% | 25.01% | 26.00% | 26.15% | 26.18% |
| No. of shareholders | 31,271 | 30,934 | 30,673 | 28,945 | 28,319 | 27,325 | 26,886 | 27,010 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Gujarat Themis Biosyn Ltd corporate filings
- Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationCompany Updatelow impact
Cruxal's analysis: Gujarat Themis Biosyn Ltd has filed a disclosure regarding amendments to its Memorandum…
Read the full analysis - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationCompany Updatelow impact
Cruxal's analysis: Gujarat Themis Biosyn Ltd has filed a disclosure regarding amendments to its Memorandum…
Read the full analysis - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAGM/EGMmedium impact
Cruxal's analysis: Gujarat Themis Biosyn Limited has received shareholder approval via postal ballot for two…
Read the full analysis - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAGM/EGMmedium impact
Cruxal's analysis: Gujarat Themis Biosyn Limited has successfully concluded its Extraordinary General…
Read the full analysis - Shareholder Meeting / Postal Ballot-Outcome of EGMAGM/EGMmedium impact
Cruxal's analysis: Gujarat Themis Biosyn Limited has successfully concluded its Extraordinary General…
Read the full analysis - Earnings Call TranscriptCompany Updatehigh impact
Cruxal's analysis: Gujarat Themis Biosyn reported Q1 FY27 revenue of INR 43.8 crore, up 22.1% YoY, with…
Read the full analysis - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeCompany Updatelow impact
Cruxal's analysis: Gujarat Themis Biosyn Ltd has formally submitted the audio recording of the investor and…
Read the full analysis - Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Gujarat Themis Biosyn Limited has released its un-audited standalone and consolidated…
Read the full analysis - Announcement under Regulation 30 (LODR)-Investor PresentationCompany Updatehigh impact
Cruxal's analysis: Gujarat Themis Biosyn Limited (GTBL) delivered a robust performance in Q1 FY27, with…
Read the full analysis - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026Board Meetinghigh impact
Cruxal's analysis: Gujarat Themis Biosyn Limited reported a strong performance for the quarter ended 30th…
Read the full analysis - The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D PatelInsider Trading / SASTlow impact
Cruxal's analysis: Gujarat Themis Biosyn Limited has reported an inter-se transfer of 5,23,560 equity shares…
Read the full analysis - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationCompany Updatelow impact
Cruxal's analysis: Gujarat Themis Biosyn Ltd has issued an intimation regarding an upcoming analyst and…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Gujarat Themis Biosyn Ltd
Cruxal reads every Gujarat Themis Biosyn Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.